Buy Spring Bank Pharmaceuticals Stock | SBPH Stock Price & Latest News | Public
SBPH

Spring Bank Pharmaceuticals

    Small Market Cap

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About SBPH

    F-star Therapeutics, Inc. is a clinical-stage immuno-oncology company. It focuses on transforming the lives of patients with cancer through the development of tetravalent mAb2 bispecific antibodies. The firm’s product candidate, FS118, simultaneously targets two immune ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.66
    -1.32
    -1.98
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$1.12

    Actual EPS
    Q4 2020

    Stats

    Market Cap$30,19M
    Volume7,11k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$19.20
    1 Year Low$3.20
    Open$6.08
    High$7.42
    Low$6.08

    Buy any stock with any amount of money.

    Download the App
    Download the app